Related Experiment Videos
Isolated myocardial perfusion during arch repair
The Annals of Thoracic Surgery
|June 1, 1990
Summary
This study introduces a modified surgical technique for aortic arch repair, utilizing isolated myocardial perfusion to protect the heart during complex aortic coarctation procedures. This method effectively reduces the time the heart muscle is deprived of blood supply.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Thoracic Surgery
Background:
- Coarctation of the aorta and interrupted aortic arch are critical congenital heart defects requiring complex surgical repair.
- Current techniques for aortic arch reconstruction can involve significant myocardial ischemic times, posing risks to cardiac function.
Purpose of the Study:
- To describe and evaluate a modified surgical technique for aortic arch reconstruction using isolated myocardial perfusion.
- To assess the impact of this technique on myocardial ischemic time during repair of severe aortic arch anomalies.
Main Methods:
- A modified surgical approach was employed in 5 patients with severe hypoplasia or interruption of the aortic arch.
- Isolated myocardial perfusion was achieved by reducing cardiopulmonary bypass flow during aortic arch repair, while the ascending aorta was cross-clamped distally.
- The heart was maintained perfused and beating throughout the aortic arch reconstruction phase.
Main Results:
- The modified technique successfully facilitated the repair of complex aortic arch anomalies in all 5 patients.
- Isolated myocardial perfusion during arch reconstruction significantly reduced the myocardial ischemic time compared to conventional methods.
- The heart remained perfused and beating during the critical arch repair period.
Conclusions:
- Isolated myocardial perfusion is a viable and effective modification for aortic arch reconstruction in complex cases.
- This technique offers significant myocardial protection by minimizing ischemic time during aortic arch repair.
- The described method holds promise for improving outcomes in neonates and infants with severe aortic arch defects.